GATA2 and acute myeloid leukemia: In this study, we further refined the biological and prognostic implications of GATA2 variant allele frequency (VAF) in adult patients with de novo cytogenetically normal AML (CN-AML) through targeted next-generation sequencing (NGS), which may help advance our understanding of the clinical effects of GATA2mut in de novo CN-AML.